A retrospective analysis of TP53 signature for predicting treatment response and prognosis in breast cancer

A retrospective analysis of TP53 signature for predicting treatment response and prognosis in breast cancer - A retrospective analysis of TP53 signature

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000046521

Enrollment

740

Registered

2022-01-04

Start date

2022-01-02

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

None listed

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: T1-3,N0-1,M0 breast cancer

Exclusion criteria

Exclusion criteria: Cases with unreliable gene expression data

Design outcomes

Primary

Measure	Time frame
Pathological complete response	—

Countries

Japan

Contacts

Public ContactShin Takahashi

Tohoku University Hospital Department of Medical Oncology

shin.takahashi.e7@tohoku.ac.jp022-717-8543

Outcome results